Index by Author

May 1, 2003; 305 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ahn, Hee B.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  2. Alessio, Enzo

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  3. Ammoun, Sylwia

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

  4. Anakk, Sayeepriyadarshini

    • Insights into Gender Bias: Rat Cytochrome P450 3A9 J Pharmacol Exp Ther May 1, 2003 305:703-709; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048090

  5. Anderes, Kenna L.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  6. Anderson, Mark B.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  7. Andrews, S. W.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  8. Arita, Makoto

    • Norepinephrine Evoked by Potassium Depolarization Increases Interstitial Adenosine Concentration via Activation of ecto-5′-Nucleotidase in Rat Hearts J Pharmacol Exp Ther May 1, 2003 305:719-724; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039917

  9. Arányi, Péter

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  10. Atchison, William D.

    • Iberiotoxin-Induced Block of Ca2+-Activated K+ Channels Induces Dihydropyridine Sensitivity of ACh Release from Mammalian Motor Nerve Terminals J Pharmacol Exp Ther May 1, 2003 305:646-652; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046102

B

  1. Babusis, D.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  2. Bae, Hae R.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  3. Banan, A.

    • The δ-Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia J Pharmacol Exp Ther May 1, 2003 305:482-494; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047308

  4. Banwait, Kuldip

    • Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter J Pharmacol Exp Ther May 1, 2003 305:615-624; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048462

  5. Bauer, Christian

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  6. Bergamo, Alberta

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  7. Besana, A.

    • Diverse Toxicity Associated with Cardiac Na+/K+ Pump Inhibition: Evaluation of Electrophysiological Mechanisms J Pharmacol Exp Ther May 1, 2003 305:765-771; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047696

  8. Bogardus, A.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  9. Bottlaender, Michel

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  10. Boucher, Richard C.

    • Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability J Pharmacol Exp Ther May 1, 2003 305:440-450; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047654

  11. Bramoulle, Yann

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  12. Bravo, A.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  13. Briz, O.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  14. Brown, David R.

    • Kinin-Induced Anion-Dependent Secretion in Porcine Ileum: Characterization and Involvement of Opioid- and Cannabinoid-Sensitive Enteric Neural Circuits J Pharmacol Exp Ther May 1, 2003 305:733-739; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047829

  15. Brownlee, Barbara A.

    • Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy J Pharmacol Exp Ther May 1, 2003 305:625-631; published ahead of print February 20, 2003, doi:10.1124/jpet.102.046987

  16. Bryant, Camron D.

    • The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice J Pharmacol Exp Ther May 1, 2003 305:755-764; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047902

  17. Burk, R. M.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  18. Bush, Eugene

    • Structure-Activity Relations of Successful Pharmacologic Chaperones for Rescue of Naturally Occurring and Manufactured Mutants of the Gonadotropin-Releasing Hormone Receptor J Pharmacol Exp Ther May 1, 2003 305:608-614; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048454

  19. Bátori, Sándor

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

C

  1. Calo, Girolamo

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

  2. Calvin, A. D.

    • Maternal Vaccination Against Nicotine Reduces Nicotine Distribution to Fetal Brain in Rats J Pharmacol Exp Ther May 1, 2003 305:587-592; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046805

  3. Calvin, Andrew

    • Kinin-Induced Anion-Dependent Secretion in Porcine Ileum: Characterization and Involvement of Opioid- and Cannabinoid-Sensitive Enteric Neural Circuits J Pharmacol Exp Ther May 1, 2003 305:733-739; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047829

  4. Carter, Lawrence P.

    • The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies J Pharmacol Exp Ther May 1, 2003 305:668-674; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047860
    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  5. Castillo, Rosemary

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  6. Castro, Mary

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  7. Chen, J.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  8. Chen, R.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  9. Chen, Weibin

    • The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies J Pharmacol Exp Ther May 1, 2003 305:668-674; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047860

  10. Chen, Xi-Lin

    • Rac1 and Superoxide Are Required for the Expression of Cell Adhesion Molecules Induced by Tumor Necrosis Factor-α in Endothelial Cells J Pharmacol Exp Ther May 1, 2003 305:573-580; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047894

  11. Cherukury, M.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  12. Chesler, Elissa J.

    • The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice J Pharmacol Exp Ther May 1, 2003 305:755-764; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047902

  13. Cho, Gyeong Jae

    • Flavonoid Baicalein Attenuates Activation-Induced Cell Death of Brain Microglia J Pharmacol Exp Ther May 1, 2003 305:638-645; published ahead of print January 21, 2003, doi:10.1124/jpet.102.047373

  14. Choi, Wan Sung

    • Flavonoid Baicalein Attenuates Activation-Induced Cell Death of Brain Microglia J Pharmacol Exp Ther May 1, 2003 305:638-645; published ahead of print January 21, 2003, doi:10.1124/jpet.102.047373

  15. Christie, Lance C.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  16. Cocchietto, Moreno

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  17. Colpaert, Francis C.

    • Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief J Pharmacol Exp Ther May 1, 2003 305:749-754; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047225

  18. Conn, P. Michael

    • Structure-Activity Relations of Successful Pharmacologic Chaperones for Rescue of Naturally Occurring and Manufactured Mutants of the Gonadotropin-Releasing Hormone Receptor J Pharmacol Exp Ther May 1, 2003 305:608-614; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048454

  19. Coop, Andrew

    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  20. Coop, Andy

    • The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies J Pharmacol Exp Ther May 1, 2003 305:668-674; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047860

  21. Copple, Bryan L.

    • Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers J Pharmacol Exp Ther May 1, 2003 305:417-425; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046391

  22. Corsini, Giovanni U.

    • An Unusual Form of the Association Binding Kinetics ofN-[3H]Methylscopolamine to the Split Muscarinic M2trunk/M2tail Receptor J Pharmacol Exp Ther May 1, 2003 305:786-795; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045393

  23. Coyne, Carolyn B.

    • Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability J Pharmacol Exp Ther May 1, 2003 305:440-450; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047654

  24. Curet, Olivier

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

D

  1. Dattilo, Michael

    • Pharmacology of δ2 Glutamate Receptors: Effects of Pentamidine and Protons J Pharmacol Exp Ther May 1, 2003 305:740-748; published ahead of print February 11, 2003, doi:10.1124/jpet.102.045799

  2. Dauer, Marc

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  3. Depoortere, Inge

    • Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum J Pharmacol Exp Ther May 1, 2003 305:660-667; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047563

  4. Detheux, Michel

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

  5. Ding, Xiaoyu

    • Rac1 and Superoxide Are Required for the Expression of Cell Adhesion Molecules Induced by Tumor Necrosis Factor-α in Endothelial Cells J Pharmacol Exp Ther May 1, 2003 305:573-580; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047894

  6. Dios-Viéitez, Marı́a Carmen

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  7. Dollé, Frédéric

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  8. Dunn, Adrian J.

    • Activation of β2- and β3-Adrenergic Receptors Increases Brain Tryptophan J Pharmacol Exp Ther May 1, 2003 305:653-659; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048249

E

  1. Eigler, Andreas

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  2. El-Masri, Hisham A.

    • Cytochrome P450 2E1 (CYP2E1) Is the Principal Enzyme Responsible for Urethane Metabolism: Comparative Studies Using CYP2E1-Null and Wild-Type Mice J Pharmacol Exp Ther May 1, 2003 305:557-564; published ahead of print January 24, 2003, doi:10.1124/jpet.103.049072

  3. Endres, Stefan

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

F

  1. Farhadi, A.

    • The δ-Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia J Pharmacol Exp Ther May 1, 2003 305:482-494; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047308

  2. Ferguson, C.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  3. Ferrari, P.

    • Diverse Toxicity Associated with Cardiac Na+/K+ Pump Inhibition: Evaluation of Electrophysiological Mechanisms J Pharmacol Exp Ther May 1, 2003 305:765-771; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047696

  4. Fields, J. Z.

    • The δ-Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia J Pharmacol Exp Ther May 1, 2003 305:482-494; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047308

  5. Finance, Olivier

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  6. Flink, Michael T.

    • Iberiotoxin-Induced Block of Ca2+-Activated K+ Channels Induces Dihydropyridine Sensitivity of ACh Release from Mammalian Motor Nerve Terminals J Pharmacol Exp Ther May 1, 2003 305:646-652; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046102

  7. Flores, Lauren R.

    • The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies J Pharmacol Exp Ther May 1, 2003 305:668-674; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047860

  8. France, Charles P.

    • The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies J Pharmacol Exp Ther May 1, 2003 305:668-674; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047860
    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  9. Freytag, Philipp

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  10. Fuseau, Chantal

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

G

  1. Ganey, Patricia E.

    • Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers J Pharmacol Exp Ther May 1, 2003 305:417-425; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046391

  2. Gao, Liping

    • α2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats J Pharmacol Exp Ther May 1, 2003 305:581-586; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047647

  3. Gardner, S. H.

    • Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells J Pharmacol Exp Ther May 1, 2003 305:632-637; published ahead of print February 11, 2003, doi:10.1124/jpet.103.048769

  4. Garrido, Marı́a J.

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  5. Garst, M. E.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  6. Gary, Keith A.

    • The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based Therapeutics J Pharmacol Exp Ther May 1, 2003 305:410-416; published ahead of print February 20, 2003, doi:10.1124/jpet.102.044040

  7. Gava, Barbara

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  8. George, Pascal

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  9. Gettys, Thomas W.

    • Activation of β2- and β3-Adrenergic Receptors Increases Brain Tryptophan J Pharmacol Exp Ther May 1, 2003 305:653-659; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048249

  10. Ghanayem, Burhan I.

    • Cytochrome P450 2E1 (CYP2E1) Is the Principal Enzyme Responsible for Urethane Metabolism: Comparative Studies Using CYP2E1-Null and Wild-Type Mice J Pharmacol Exp Ther May 1, 2003 305:557-564; published ahead of print January 24, 2003, doi:10.1124/jpet.103.049072

  11. Gil, D. W.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  12. Giles, Belinda E.

    • The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice J Pharmacol Exp Ther May 1, 2003 305:755-764; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047902

  13. Gilmor, Michelle L.

    • The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems J Pharmacol Exp Ther May 1, 2003 305:434-439; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045419

  14. Gonzalez, Frank J.

    • Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? J Pharmacol Exp Ther May 1, 2003 305:403-409; published ahead of print January 24, 2003, doi:10.1124/jpet.102.039925

  15. Goulet, Mark

    • Structure-Activity Relations of Successful Pharmacologic Chaperones for Rescue of Naturally Occurring and Manufactured Mutants of the Gonadotropin-Releasing Hormone Receptor J Pharmacol Exp Ther May 1, 2003 305:608-614; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048454

  16. Green, Benedict T.

    • Kinin-Induced Anion-Dependent Secretion in Porcine Ileum: Characterization and Involvement of Opioid- and Cannabinoid-Sensitive Enteric Neural Circuits J Pharmacol Exp Ther May 1, 2003 305:733-739; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047829

  17. Greer, Jonathan

    • Structure-Activity Relations of Successful Pharmacologic Chaperones for Rescue of Naturally Occurring and Manufactured Mutants of the Gonadotropin-Releasing Hormone Receptor J Pharmacol Exp Ther May 1, 2003 305:608-614; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048454

  18. Gregory, Margaret L.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  19. Grobin, A. C.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  20. Guenther, Ilonka

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  21. Gulinello, M.

    • Anxiogenic Effects of Neurosteroid Exposure: Sex Differences and Altered GABAA Receptor Pharmacology in Adult Rats J Pharmacol Exp Ther May 1, 2003 305:541-548; published ahead of print February 11, 2003, doi:10.1124/jpet.102.045120

H

  1. Hallwachs, Roland

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  2. Hammerling, Ulrich

    • Regulation of the Cardiac Mitochondrial Membrane Potential by Retinoids J Pharmacol Exp Ther May 1, 2003 305:426-433; published ahead of print January 24, 2003, doi:10.1124/jpet.103.048900

  3. Hanumegowda, Umesh M.

    • Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers J Pharmacol Exp Ther May 1, 2003 305:417-425; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046391

  4. Hawcroft, G.

    • Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells J Pharmacol Exp Ther May 1, 2003 305:632-637; published ahead of print February 11, 2003, doi:10.1124/jpet.103.048769

  5. Hernandez, R. Jason

    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  6. Hines, Ronald N.

    • Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? J Pharmacol Exp Ther May 1, 2003 305:403-409; published ahead of print January 24, 2003, doi:10.1124/jpet.102.039925

  7. Hoffler, Undi

    • Cytochrome P450 2E1 (CYP2E1) Is the Principal Enzyme Responsible for Urethane Metabolism: Comparative Studies Using CYP2E1-Null and Wild-Type Mice J Pharmacol Exp Ther May 1, 2003 305:557-564; published ahead of print January 24, 2003, doi:10.1124/jpet.103.049072

  8. Holmqvist, Tomas

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

  9. Homanics, G. E.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  10. Hull, M. A.

    • Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells J Pharmacol Exp Ther May 1, 2003 305:632-637; published ahead of print February 11, 2003, doi:10.1124/jpet.103.048769

I

  1. Iengo, Elisabetta

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  2. Igarashi., Kazuei

    • Pharmacology of δ2 Glutamate Receptors: Effects of Pentamidine and Protons J Pharmacol Exp Ther May 1, 2003 305:740-748; published ahead of print February 11, 2003, doi:10.1124/jpet.102.045799

  3. Inoue, Atsuko

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

  4. Inoue, Makoto

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

J

  1. Jackson, Edwin K.

    • α2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats J Pharmacol Exp Ther May 1, 2003 305:581-586; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047647

  2. Janovick, Jo Ann

    • Structure-Activity Relations of Successful Pharmacologic Chaperones for Rescue of Naturally Occurring and Manufactured Mutants of the Gonadotropin-Releasing Hormone Receptor J Pharmacol Exp Ther May 1, 2003 305:608-614; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048454

  3. Jegham, Jamir

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  4. Jin, Xi-Lu

    • Differential Regulation of the Human κ Opioid Receptor by Agonists: Etorphine and Levorphanol Reduced Dynorphin A- and U50,488H-Induced Internalization and Phosphorylation J Pharmacol Exp Ther May 1, 2003 305:531-540; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045559

  5. John, Gareth W.

    • Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief J Pharmacol Exp Ther May 1, 2003 305:749-754; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047225

  6. Johnson, Larry G.

    • Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability J Pharmacol Exp Ther May 1, 2003 305:440-450; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047654

K

  1. Kang, Sang Soo

    • Flavonoid Baicalein Attenuates Activation-Induced Cell Death of Brain Microglia J Pharmacol Exp Ther May 1, 2003 305:638-645; published ahead of print January 21, 2003, doi:10.1124/jpet.102.047373

  2. Kapp, Joachim Friedrich

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  3. Kapui, Zoltán

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  4. Kapur, Shitij

    • Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy J Pharmacol Exp Ther May 1, 2003 305:625-631; published ahead of print February 20, 2003, doi:10.1124/jpet.102.046987

  5. Kashiwagi, Keiko

    • Pharmacology of δ2 Glutamate Receptors: Effects of Pentamidine and Protons J Pharmacol Exp Ther May 1, 2003 305:740-748; published ahead of print February 11, 2003, doi:10.1124/jpet.102.045799

  6. Kawashima, Toshiko

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

  7. Kazerounian, Shiva

    • Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter J Pharmacol Exp Ther May 1, 2003 305:615-624; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048462

  8. Kedzie, K. M.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  9. Keshavarzian, A.

    • The δ-Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia J Pharmacol Exp Ther May 1, 2003 305:482-494; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047308

  10. Keyler, D. E.

    • Maternal Vaccination Against Nicotine Reduces Nicotine Distribution to Fetal Brain in Rats J Pharmacol Exp Ther May 1, 2003 305:587-592; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046805

  11. Kharlamb, A.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  12. Kim, Jong-M.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  13. Korichneva, Irina

    • Regulation of the Cardiac Mitochondrial Membrane Potential by Retinoids J Pharmacol Exp Ther May 1, 2003 305:426-433; published ahead of print January 24, 2003, doi:10.1124/jpet.103.048900

  14. Kralic, J. E.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  15. Krauss, A. H.-P.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  16. Krauss, H. A.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  17. Kraynov, Eugenia A.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  18. Ku, Chun Ying

    • Insights into Gender Bias: Rat Cytochrome P450 3A9 J Pharmacol Exp Ther May 1, 2003 305:703-709; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048090

  19. Kukkonen, Jyrki P.

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

L

  1. LaRose, Lori

    • Block of Na+,K+-ATPase and Induction of Hybrid Death by 4-Aminopyridine in Cultured Cortical Neurons J Pharmacol Exp Ther May 1, 2003 305:502-506; published ahead of print January 21, 2003, doi:10.1124/jpet.102.045013

  2. Lamb, Richard

    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  3. Landauer, Nikola

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  4. Lariviere, William R.

    • The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice J Pharmacol Exp Ther May 1, 2003 305:755-764; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047902

  5. Lash, Lawrence H.

    • Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? J Pharmacol Exp Ther May 1, 2003 305:403-409; published ahead of print January 24, 2003, doi:10.1124/jpet.102.039925

  6. Le Grand, Bruno

    • Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief J Pharmacol Exp Ther May 1, 2003 305:749-754; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047225

  7. LeSage, M. G.

    • Maternal Vaccination Against Nicotine Reduces Nicotine Distribution to Fetal Brain in Rats J Pharmacol Exp Ther May 1, 2003 305:587-592; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046805

  8. Lee, Heasuk

    • Flavonoid Baicalein Attenuates Activation-Induced Cell Death of Brain Microglia J Pharmacol Exp Ther May 1, 2003 305:638-645; published ahead of print January 21, 2003, doi:10.1124/jpet.102.047373

  9. Lee, Je M.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  10. Lee, Matthew C.

    • The Role of Several Kinases in Mice Tolerant to Δ9-Tetrahydrocannabinol J Pharmacol Exp Ther May 1, 2003 305:593-599; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044446

  11. Lehr, Hans-Anton

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  12. Lenard, Natalie R.

    • Activation of β2- and β3-Adrenergic Receptors Increases Brain Tryptophan J Pharmacol Exp Ther May 1, 2003 305:653-659; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048249

  13. Li, C.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  14. Li, Jian-Guo

    • Differential Regulation of the Human κ Opioid Receptor by Agonists: Etorphine and Levorphanol Reduced Dynorphin A- and U50,488H-Induced Internalization and Phosphorylation J Pharmacol Exp Ther May 1, 2003 305:531-540; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045559

  15. Liang, Y.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  16. Liu-Chen, Lee-Yuan

    • Differential Regulation of the Human κ Opioid Receptor by Agonists: Etorphine and Levorphanol Reduced Dynorphin A- and U50,488H-Induced Internalization and Phosphorylation J Pharmacol Exp Ther May 1, 2003 305:531-540; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045559

  17. Loher, Florian

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  18. Luthin, David R.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  19. Létienne, Robert

    • Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief J Pharmacol Exp Ther May 1, 2003 305:749-754; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047225

M

  1. Macias, R. I. R.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  2. Maggio, Roberto

    • An Unusual Form of the Association Binding Kinetics ofN-[3H]Methylscopolamine to the Split Muscarinic M2trunk/M2tail Receptor J Pharmacol Exp Ther May 1, 2003 305:786-795; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045393

  3. Marin, J. J. G.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  4. Markus, Regina P.

    • Melatonin Nocturnal Surge Modulates Nicotinic Receptors and Nicotine-Induced [3H]Glutamate Release in Rat Cerebellum Slices J Pharmacol Exp Ther May 1, 2003 305:525-530; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045625

  5. May, John M.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  6. Medford, Russell M.

    • Rac1 and Superoxide Are Required for the Expression of Cell Adhesion Molecules Induced by Tumor Necrosis Factor-α in Endothelial Cells J Pharmacol Exp Ther May 1, 2003 305:573-580; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047894

  7. Mehta, Ashok K.

    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  8. Meier, P. J.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  9. Micheletti, R.

    • Diverse Toxicity Associated with Cardiac Na+/K+ Pump Inhibition: Evaluation of Electrophysiological Mechanisms J Pharmacol Exp Ther May 1, 2003 305:765-771; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047696

  10. Mikus, Endre

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  11. Miller, Richard J.

    • Direct Interactions between the Heterotrimeric G Protein Subunit Gβ5 and the G Protein γ Subunit-Like Domain-Containing Regulator of G Protein Signaling 11: Gain of Function of Cyan Fluorescent Protein-Tagged Gγ3 J Pharmacol Exp Ther May 1, 2003 305:460-466; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048637

  12. Mogil, Jeffrey S.

    • The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice J Pharmacol Exp Ther May 1, 2003 305:755-764; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047902

  13. Morrow, A. L.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  14. Mostacciuolo, G.

    • Diverse Toxicity Associated with Cardiac Na+/K+ Pump Inhibition: Evaluation of Electrophysiological Mechanisms J Pharmacol Exp Ther May 1, 2003 305:765-771; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047696

  15. Moulin, Frederic

    • Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers J Pharmacol Exp Ther May 1, 2003 305:417-425; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046391

N

  1. Nakata, Yoshihiro

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

  2. Nared-Hood, Karen

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  3. Nemeroff, Charles B.

    • The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems J Pharmacol Exp Ther May 1, 2003 305:434-439; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045419

  4. Nobrega, José N.

    • Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy J Pharmacol Exp Ther May 1, 2003 305:625-631; published ahead of print February 20, 2003, doi:10.1124/jpet.102.046987

  5. Novi, Francesca

    • An Unusual Form of the Association Binding Kinetics ofN-[3H]Methylscopolamine to the Split Muscarinic M2trunk/M2tail Receptor J Pharmacol Exp Ther May 1, 2003 305:786-795; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045393

O

  1. O'Buckley, T. K.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  2. O'Donnell, James M.

    • Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram J Pharmacol Exp Ther May 1, 2003 305:565-572; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047407

  3. O'Grady, Scott M.

    • Kinin-Induced Anion-Dependent Secretion in Porcine Ileum: Characterization and Involvement of Opioid- and Cannabinoid-Sensitive Enteric Neural Circuits J Pharmacol Exp Ther May 1, 2003 305:733-739; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047829

  4. Obata, Toshio

    • Norepinephrine Evoked by Potassium Depolarization Increases Interstitial Adenosine Concentration via Activation of ecto-5′-Nucleotidase in Rat Hearts J Pharmacol Exp Ther May 1, 2003 305:719-724; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039917

  5. Olsen, Michael S.

    • The Heritability of Antinociception II: Pharmacogenetic Mediation of Three Over-the-Counter Analgesics in Mice J Pharmacol Exp Ther May 1, 2003 305:755-764; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047902

  6. Oonk, Hendrica B.

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

  7. Owens, Michael J.

    • The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems J Pharmacol Exp Ther May 1, 2003 305:434-439; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045419

P

  1. Paderes, Genevieve

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  2. Park, Bong S.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  3. Park, Woo C.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  4. Parmentier, Marc

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

  5. Pascual, M. J.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  6. Pathak, Ved P.

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  7. Peeters, Theo L.

    • Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum J Pharmacol Exp Ther May 1, 2003 305:660-667; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047563

  8. Pentel, P. R.

    • Maternal Vaccination Against Nicotine Reduces Nicotine Distribution to Fetal Brain in Rats J Pharmacol Exp Ther May 1, 2003 305:587-592; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046805

  9. Perez, Michel

    • Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief J Pharmacol Exp Ther May 1, 2003 305:749-754; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047225

  10. Pinquier, Jean-Louis

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  11. Prange, Arthur J.

    • The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based Therapeutics J Pharmacol Exp Ther May 1, 2003 305:410-416; published ahead of print February 20, 2003, doi:10.1124/jpet.102.044040

  12. Protzman, C. E.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

Q

  1. Qian, XuanXuan

    • Endogenous Opioid Peptides Contribute to Antinociceptive Potency of Intrathecal [Dmt1]DALDA J Pharmacol Exp Ther May 1, 2003 305:696-702; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048561

R

  1. Rapado, Javier

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  2. Rathi, Sandeep

    • Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter J Pharmacol Exp Ther May 1, 2003 305:615-624; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048462

  3. Rattan, Satish

    • Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter J Pharmacol Exp Ther May 1, 2003 305:615-624; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048462

  4. Renedo, Marı́a Jesús

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  5. Renzi, K.

    • Deletion of GABAA Receptor α1 Subunit-containing Receptors Alters Responses to Ethanol and Other Anesthetics J Pharmacol Exp Ther May 1, 2003 305:600-607; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048124

  6. Renó, Lı́via A. C.

    • Melatonin Nocturnal Surge Modulates Nicotinic Receptors and Nicotine-Induced [3H]Glutamate Release in Rat Cerebellum Slices J Pharmacol Exp Ther May 1, 2003 305:525-530; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045625

  7. Rho, Jee H.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  8. Rho, Sae H.

    • Early Mitochondrial Hyperpolarization and Intracellular Alkalinization in Lactacystin-Induced Apoptosis of Retinal Pigment Epithelial Cells J Pharmacol Exp Ther May 1, 2003 305:474-481; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047811

  9. Ribeiro, Carla M. P.

    • Acute Mechanism of Medium Chain Fatty Acid-Induced Enhancement of Airway Epithelial Permeability J Pharmacol Exp Ther May 1, 2003 305:440-450; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047654

  10. Rieder, Florian

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  11. Robberecht, Patrick

    • Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum J Pharmacol Exp Ther May 1, 2003 305:660-667; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047563

  12. Rocchetti, M.

    • Diverse Toxicity Associated with Cardiac Na+/K+ Pump Inhibition: Evaluation of Electrophysiological Mechanisms J Pharmacol Exp Ther May 1, 2003 305:765-771; published ahead of print February 20, 2003, doi:10.1124/jpet.102.047696

  13. Roth, Robert A.

    • Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers J Pharmacol Exp Ther May 1, 2003 305:417-425; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046391

  14. Rothstein, Mark A.

    • Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile? J Pharmacol Exp Ther May 1, 2003 305:403-409; published ahead of print January 24, 2003, doi:10.1124/jpet.102.039925

  15. Roumenov, Dimitri

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

S

  1. Sabado, Thomas N.

    • Pharmacology of δ2 Glutamate Receptors: Effects of Pentamidine and Protons J Pharmacol Exp Ther May 1, 2003 305:740-748; published ahead of print February 11, 2003, doi:10.1124/jpet.102.045799

  2. Santos, Jussara M.

    • Melatonin Nocturnal Surge Modulates Nicotinic Receptors and Nicotine-Induced [3H]Glutamate Release in Rat Cerebellum Slices J Pharmacol Exp Ther May 1, 2003 305:525-530; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045625

  3. Sava, Gianni

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  4. Sayar, Onintza

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  5. Scarselli, Marco

    • An Unusual Form of the Association Binding Kinetics ofN-[3H]Methylscopolamine to the Split Muscarinic M2trunk/M2tail Receptor J Pharmacol Exp Ther May 1, 2003 305:786-795; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045393

  6. Schmall, Kathrin

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  7. Schulz, Stephanie

    • Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter J Pharmacol Exp Ther May 1, 2003 305:615-624; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048462

  8. Segura, Cristina

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  9. Serli, Barbara

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  10. Serrano, M. A.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  11. Sevarino, Kevin A.

    • The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based Therapeutics J Pharmacol Exp Ther May 1, 2003 305:410-416; published ahead of print February 20, 2003, doi:10.1124/jpet.102.044040

  12. Shaikh, M.

    • The δ-Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia J Pharmacol Exp Ther May 1, 2003 305:482-494; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047308

  13. Shariatmadari, Ramin

    • Distinct Recognition of OX1 and OX2Receptors by Orexin Peptides J Pharmacol Exp Ther May 1, 2003 305:507-514; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048025

  14. Shi, Wei-Xing

    • Dendritic Glutamate-Induced Bursting in the Prefrontal Cortex: Further Characterization and Effects of Phencyclidine J Pharmacol Exp Ther May 1, 2003 305:680-687; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046359

  15. Shoeman, D.

    • Maternal Vaccination Against Nicotine Reduces Nicotine Distribution to Fetal Brain in Rats J Pharmacol Exp Ther May 1, 2003 305:587-592; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046805

  16. Siegmund, Britta

    • The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice J Pharmacol Exp Ther May 1, 2003 305:549-556; published ahead of print February 11, 2003, doi:10.1124/jpet.102.039529

  17. Skelton, Kelly H.

    • The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems J Pharmacol Exp Ther May 1, 2003 305:434-439; published ahead of print January 24, 2003, doi:10.1124/jpet.102.045419

  18. Smith, Forrest L.

    • The Role of Several Kinases in Mice Tolerant to Δ9-Tetrahydrocannabinol J Pharmacol Exp Ther May 1, 2003 305:593-599; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044446

  19. Smith, S. S.

    • Anxiogenic Effects of Neurosteroid Exposure: Sex Differences and Altered GABAA Receptor Pharmacology in Adult Rats J Pharmacol Exp Ther May 1, 2003 305:541-548; published ahead of print February 11, 2003, doi:10.1124/jpet.102.045120

  20. Soong, Yi

    • Endogenous Opioid Peptides Contribute to Antinociceptive Potency of Intrathecal [Dmt1]DALDA J Pharmacol Exp Ther May 1, 2003 305:696-702; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048561

  21. St-Pierre, M. V.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  22. Stevens, David L.

    • The Role of Several Kinases in Mice Tolerant to Δ9-Tetrahydrocannabinol J Pharmacol Exp Ther May 1, 2003 305:593-599; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044446

  23. Stieger, B.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  24. Stocco, Gabriele

    • Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines J Pharmacol Exp Ther May 1, 2003 305:725-732; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047803

  25. Strobel, Henry W.

    • Insights into Gender Bias: Rat Cytochrome P450 3A9 J Pharmacol Exp Ther May 1, 2003 305:703-709; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048090

  26. Suk, Kyoungho

    • Flavonoid Baicalein Attenuates Activation-Induced Cell Death of Brain Microglia J Pharmacol Exp Ther May 1, 2003 305:638-645; published ahead of print January 21, 2003, doi:10.1124/jpet.102.047373

  27. Szabó, Tibor

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  28. Szeredi, Judit

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  29. Szeto, Hazel H.

    • Endogenous Opioid Peptides Contribute to Antinociceptive Potency of Intrathecal [Dmt1]DALDA J Pharmacol Exp Ther May 1, 2003 305:696-702; published ahead of print January 24, 2003, doi:10.1124/jpet.102.048561

T

  1. Takeshima, Hiroshi

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

  2. Tang-Liu, D. D.-S.

    • Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) J Pharmacol Exp Ther May 1, 2003 305:772-785; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047837

  3. Thielemans, Leen

    • Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum J Pharmacol Exp Ther May 1, 2003 305:660-667; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047563

  4. Thijs, Theo

    • Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum J Pharmacol Exp Ther May 1, 2003 305:660-667; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047563

  5. Ticku, Maharaj K.

    • A Tertiary Alcohol Analog of γ-Hydroxybutyric Acid as a Specific γ-Hydroxybutyric Acid Receptor Ligand J Pharmacol Exp Ther May 1, 2003 305:675-679; published ahead of print January 21, 2003, doi:10.1124/jpet.102.046797

  6. Toth, Peter T.

    • Direct Interactions between the Heterotrimeric G Protein Subunit Gβ5 and the G Protein γ Subunit-Like Domain-Containing Regulator of G Protein Signaling 11: Gain of Function of Cyan Fluorescent Protein-Tagged Gγ3 J Pharmacol Exp Ther May 1, 2003 305:460-466; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048637

  7. Trocóniz, Iñaki F.

    • Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity J Pharmacol Exp Ther May 1, 2003 305:710-718; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047779

  8. Tummala, Pradyumna E.

    • Rac1 and Superoxide Are Required for the Expression of Cell Adhesion Molecules Induced by Tumor Necrosis Factor-α in Endothelial Cells J Pharmacol Exp Ther May 1, 2003 305:573-580; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047894

U

  1. Ueda, Hiroshi

    • In Vivo Pain-Inhibitory Role of Nociceptin/Orphanin FQ in Spinal Cord J Pharmacol Exp Ther May 1, 2003 305:495-501; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046326

  2. Unzeitig, Andrew W.

    • The Role of GABAB Receptors in the Discriminative Stimulus Effects of γ-Hydroxybutyrate in Rats: Time Course and Antagonism Studies J Pharmacol Exp Ther May 1, 2003 305:668-674; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047860

  3. Urban-Szabó, Katalin

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

V

  1. Valette, Heric

    • Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone J Pharmacol Exp Ther May 1, 2003 305:467-473; published ahead of print February 11, 2003, doi:10.1124/jpet.102.046953

  2. Vallejo, M.

    • Effect of Ursodeoxycholic Acid on the Impairment Induced by Maternal Cholestasis in the Rat Placenta-Maternal Liver Tandem Excretory Pathway J Pharmacol Exp Ther May 1, 2003 305:515-524; published ahead of print January 24, 2003, doi:10.1124/jpet.102.047977

  3. VanderSpek, Susan C.

    • Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy J Pharmacol Exp Ther May 1, 2003 305:625-631; published ahead of print February 20, 2003, doi:10.1124/jpet.102.046987

  4. Varga, Márton

    • Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor J Pharmacol Exp Ther May 1, 2003 305:451-459; published ahead of print February 11, 2003, doi:10.1124/jpet.102.044263

  5. Vazir, Haresh

    • Biological Characterization of a Novel, Orally Active Small Molecule Gonadotropin-Releasing Hormone (GnRH) Antagonist Using Castrated and Intact Rats J Pharmacol Exp Ther May 1, 2003 305:688-695; published ahead of print January 24, 2003, doi:10.1124/jpet.102.046656

  6. Verscheure, Yvan

    • Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief J Pharmacol Exp Ther May 1, 2003 305:749-754; published ahead of print February 11, 2003, doi:10.1124/jpet.102.047225

  7. Vore, Mary

    • Insights into Gender Bias: Rat Cytochrome P450 3A9 J Pharmacol Exp Ther May 1, 2003 305:703-709; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048090

W

  1. Waka, John

    • Regulation of the Cardiac Mitochondrial Membrane Potential by Retinoids J Pharmacol Exp Ther May 1, 2003 305:426-433; published ahead of print January 24, 2003, doi:10.1124/jpet.103.048900

  2. Waldman, Scott A.

    • Functional and Molecular Characterization of β-Adrenoceptors in the Internal Anal Sphincter J Pharmacol Exp Ther May 1, 2003 305:615-624; published ahead of print February 11, 2003, doi:10.1124/jpet.102.048462

  3. Wang, Xue Qing

    • Block of Na+,K+-ATPase and Induction of Hybrid Death by 4-Aminopyridine in Cultured Cortical Neurons J Pharmacol Exp Ther May 1, 2003 305:502-506; published ahead of print January 21, 2003, doi:10.1124/jpet.102.045013

  4. Wei, Ling

    • Block of Na+,K+-ATPase and Induction of Hybrid Death by 4-Aminopyridine in Cultured Cortical Neurons J Pharmacol Exp Ther May 1, 2003 305:502-506; published ahead of print January 21, 2003, doi:10.1124/jpet.102.045013